Diseases Market Research

Reportbuyer.com helps you stay ahead with advanced reports on Diseases. Information includes Competitive Positioning, Stakeholder Opinions and Future Market Watch.

Stay up-to-date with new products added to this category

Results 201 - 300 of 433 go to 1st page

first

previous 1 2 3 4 5 next

last

Title	Date	Price
Integrin Antagonists Competitor Analysis	Jun 2008	£225
Cancer Antibodies Competitive Positioning for Success	Jun 2008	£1,780
U.S. Osteoporosis Market	Jun 2008	£3,605
Innovations in the Management of Diabetes Next generation treatments and market dynamics	Jun 2008	£1,200
Alzheimer's and Parkinson's Disease	May 2008	£2,375
CNS Therapeutics	May 2008	£2,375
Cancer Therapeutics Markets	May 2008	£2,075
Cancer Vaccines Aim and Shoot	May 2008	£1,780
Heat shock protein 90 (Hsp90) Inhibitors Competitor Analysis	May 2008	£110
NGF Agonists and Antagonists Competitor Analysis	May 2008	£89
Worldwide Endoscopy Market Technology Driving Growth	May 2008	£485
CNS Generic Drugs: Prospects and Opportunities to 2012	Apr 2008	£995
Stakeholder Opinions: Percutaneous Coronary Intervention Adverse events with drug-eluting stents demand a new safety standard	Apr 2008	£2,290
Stakeholder Opinions: Heart Failure When drugs do not work	Apr 2008	£2,290
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market	Apr 2008	£7,990
Commercial Insight: CNS Market Overview Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors	Apr 2008	£7,990
Commercial and Pipeline Insight: ADHD Immature adult market continues to offer greatest commercial potential	Apr 2008	£7,990
Strategic Analysis of the Kenyan Diabetes Markets	Apr 2008	£4,510
European Markets for Fibromyalgia Syndrome	Apr 2008	£3,605
Companion Diagnostics in Personalized Medicine and Cancer Therapy	Apr 2008	£2,105
Strategic Analysis of the Kenyan Hypertension Markets	Apr 2008	£4,510
Inflammatory Directions Strategies for Six Diseases with Unmet Needs	Apr 2008	£675
Biomarker Technology Platforms for Cancer Diagnoses and Therapies	Apr 2008	£2,075
CD40 and CD40L (CD154) Agonists and Antagonists Brief Report	Apr 2008	£225
Cancer Diagnostic Testing World Markets	Apr 2008	£2,105
Pipeline and Commercial Insight: Alzheimer's Disease Scenario Forecasts Reveal Vast Market Potential	Mar 2008	£9,140
Stakeholder Opinions: Sepsis The Critical Care Community Gains Critical Mass	Mar 2008	£2,280
Stakeholder Opinions: Biologics in Infectious Diseases Well Defined Target Populations Are Key to Commercial Success	Mar 2008	£2,280
Canada Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Italy Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
UK Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Spain Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
France Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Germany Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Israel Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
US Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Republic of Korea Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Australia Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Japan Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Netherlands Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Belgium Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Argentina Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
North America Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Brazil Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Mexico Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Stakeholder Opinions: Bone Metastases Impending Patent Expiries May Help Make or Break Newer Agents	Mar 2008	£2,280
Europe Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Asia Pacific Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Egypt Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Stakeholder Opinions: Systemic Lupus Erythematosus Market Set to Enter Era of Biologic Therapies	Mar 2008	£2,280
South Africa Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Middle East & Africa Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
South & Central America Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£1,855
Global Diabetic/Diabetes Care Devices Industry Report	Mar 2008	£2,475
Rheumatoid Arthritis Drug Discoveries: what the future holds	Mar 2008	£995
Anti-Obesity Biologics Competitor Analysis	Mar 2008	£89
Advances in Disease Theranostics (Technical Insights)	Mar 2008	£3,910
Osteoporosis Therapeutics	Mar 2008	£2,375
Advances and Emerging Trends in Diabetes Monitoring Technologies (Technical Insights)	Mar 2008	£3,910
Pain Management	Mar 2008	£2,375
Cancer Cell Therapy Markets	Mar 2008	£2,075
U.S. Breast Cancer Therapeutics Markets	Mar 2008	£3,605
The Worldwide Market for Cancer Diagnostics 3rd Edition	Mar 2008	£2,400
Cardiac Toxicity	Mar 2008	£1,495
Interleukin-13 (IL-13) Antibodies Brief Report	Feb 2008	£270
Systemic Lupus Erythematosus (SLE) Competitor Analysis	Feb 2008	£180
Syk Kinase Inhibitors Brief Report	Feb 2008	£135
Interleukin-12 (IL-12) and IL-23 Antagonists Brief Report	Feb 2008	£135
Key Sub-Saharan African Infectious Disease Pharmaceutical Markets	Feb 2008	£3,605
Cardiovascular Disorders Market Outlook to 2012, The	Feb 2008	£2,305
Cancer Therapies: Technologies and Global Markets	Jan 2008	£2,915
Diabetes Therapies & Diagnostics: Global Markets	Jan 2008	£2,915
Parkinson's Disease Market analysis and forecasts 2008-2012, 2017 & 2022	Jan 2008	£1,499
Cancer Stem Cells Emerging Therapeutic, Diagnostic and Market Opportunities (2008)	Jan 2008	£1,600
GM-CSF Antibodies Brief Report	Jan 2008	£180
Peripheral Neuropathy and Neuropathic Pain, 2008 Current, Pipeline And Emerging Drugs For The Treatment Of Peripheral Neuropathy And Neuropathic Pain	Jan 2008	£1,499
Death Receptors TRAIL-R1/2 Brief Report	Jan 2008	£180
The Cancer Market Outlook to 2012	Jan 2008	£2,305
Commercial Insight: Infectious Diseases Overview	Dec 2007	£9,140
Pipeline and Commercial Insight: Urinary Incontinence Lifecycle Management Strategies Retain Mid-Term Market Growth	Dec 2007	£9,140
Stakeholder Insight: Diabetes	Dec 2007	£9,140
Stakeholder Insight: Parkinson's Disease Evidence of Neuroprotection Essential to Progress Treatment Dynamics	Dec 2007	£9,140
Stakeholder Opinions: Endometriosis Scientific Clarity Will Unlock Market Potential	Dec 2007	£2,280
Stakeholder Opinions: Hepatitis C Small-Molecule Antivirals Pave The Way for Triple Therapy	Dec 2007	£2,280
Stakeholder Insight: Inflammatory Bowel Disease Debate over Early Aggressive Treatment Continues	Dec 2007	£9,140
Pipeline Insight: Substance Dependence - Part II Alcohol	Dec 2007	£4,570
Pipeline Perspectives:Peripheral Artery Disease Poor Disease Awareness Hinders New Agents	Dec 2007	£4,570
Pipeline Insight: HIV Novel NNRTIs Address Crucial Unmet Need	Dec 2007	£6,855
Stakeholder Opinions: Non-Hodgkin's Lymphoma Is There Room to Emulate Rituxan's Success?	Dec 2007	£2,280
Stakeholder Opinions: Myelodysplastic Syndromes First Approvals Spur Some Interest in a Niche Market	Dec 2007	£2,280
Stakeholder Opinions: Head and Neck Cancer	Nov 2007	£2,280
Who's Developing What in New Cancer Drugs?	Nov 2007	£495
Pipeline Insight: Orphan Diseases in CNS - Part I: Huntington's Disease	Nov 2007	£4,570
Commercial and Pipeline Insight: Systemic antifungals	Nov 2007	£9,140
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology	Nov 2007	£1,790
Pipeline Insight: Molecular Targeted Cancer Therapies Can anything else revolutionize the market? - Cancer	Oct 2007	£9,140
Alzheimer's Disease Market analysis and forecasts, 2007-2012, 2017 & 2022	Oct 2007	£1,499
The World Diabetes Market, 2006-2012, 2017, 2025 A Key Pharmaceutical Market of the Future	Oct 2007	£1,499
The CNS Market Outlook To 2012	Oct 2007	£1,730